mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.9 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |